Three questions to

Prof. Börje Sellergren (Biofilm Research Center for Biointerfaces, Malmö University) about his project “Biomimetic sensors for the rapid detection of the SARS-CoV-2 virus”.

What´s the novelty with this project? 
Our reversible self-assembled monolayers (rSAMs) can be seen as rugged mimics of lipid bilayer membranes which can be used to boost sensitivity in virus detection to very high levels. This project focuses on adapting rSAMs to SARS-Cov-2 detection in a fiberoptic nanoplasmonic sensor format featuring low cost, fast response and ruggedness for monitoring of health status or for environmental virus surveillance.

Future implications?
The need for rapid response upon pandemic threats suggests that a new generation quick tests are needed that are not relying on slow to develop antibodies or PCR. We use a mobile epitope approach to mimic the host cell ACE2 receptor in a simple, robust and affordable construct that are easy to produce. With only small changes to the design we can therefore rapidly adapt the sensors/tests to the new virus variants, which is not easy to achieve with alternative approaches.

What´s next? 
We are currently validating the first generation sensor in collaboration with optical sensor experts in Linköping. Preliminary results have shown the sensor to bind the virus with affinities exceeding the host-cell virus interactions in simple model systems. Key now is to investigate the cross reactivity with other virus variants, to tune the mobile epitope design and to test the sensors in relevant bio- or environmental matrices.

For more info about the project please contact Börje Sellergren,

Foto: Leif Johansson


Research highlights from NanoMed North members

If you would like to share a publication within the nanomedicine area please contact

• Membrane Interactions of virus-like mesoporous silica nanoparticles Antimicrobial peptides

(AMPs) are a class of compounds that are attracting interest due to the increase in antibiotic resistance among bacteria. Virus-like mesoporous nanoparticles could be of interest as delivery systems for AMPs. Find out more about this research here.

•  Electrochemical methods for monitoring of bacterial growth

Electrochemical methods are of importance for microbial diagnostics and are commonly employed in biosensors. This work demonstrates the use of a single-well organic electrochemical transistor (OECT) to monitor bacterial growth in real-time. Read more about this research here.

• Optimizing gold nanoparticle-assisted plasmonic photothermal therapy

Gold nanorod-assisted plasmonic photothermal therapy (PPTT) has emerged as a promising treatment for cancer. Findings in this study can have a positive impact on the use and optimization of PPTT in combating tumors. Read more about this research here.

It will take place on Thursday, September 16, 2021 and will be an online event like last year.

Please check out the full program at
While the Vancouver Nanomedicine Day 2021 is free – thanks to our sponsors – registration is required at the above website.

Unfortunately, there won’t be a Copenhagen Nanomedicine Day this year. However, we’d like to invite you to spend an evening together with your nanomedicine colleagues at the Vancouver Nanomedicine Day 2021 in Vancouver, Canada. The talks will start at 17:00 Copenhagen time, and end at 23:00. It would be wonderful to have you join us. Read on for more details!

This year’s keynote speaker is Dr. Drew Weissman from the University of Pennsylvania, a physician-scientist best known for his contributions to RNA biology, which directly enabled the development of the covid-19 mRNA vaccines. Other contributions from international scientists include Dr. David Brayden from the University College Dublin who will update us on “Nanomedicines for oral peptide delivery”, and Dr. Anna Rosell from the Vall d’Hebron Research Institute in Barcelona who will tell us about “Magnetic nanocarriers targeting brain delivery after stroke”.
Please check out the detailed program that includes another 10 outstanding talks. They will cover not only different radioactive nanomedicines, but also nanomedicine delivery for the treatment of infections, HIV, SARS-Cov-2 and cancer. Polymeric nanoparticles, aptamers, and of course lipid nanoparticles are discussed that aim to target the brain, genetic diseases and atherosclerosis.
We are looking forward to spending a few hours with you during this year’s Vancouver Nanomedicine Day.
Dr. Urs Hafeli
Professor, Faculty of Pharmaceutical Sciences
University of British Columbia
PS: Please don’t hesitate to forward this email to your colleagues who might be interested in nanomedicines. Everybody is welcome!

15 -18 November 2021 | Guangzhou, China

Conference deadlines
Extended abstract submission deadline: 2 July 2021
Early bird registration deadline: 17 September 2021

Conference topics

  • Nanotechnology for Flexible electronics and Brain-machine interface
  • Nanotechnology for COVID-19`s protection, diagnosis, treatment, and vaccine
  • Advanced 2D materials and applications
  • Analytical nanoscience & technologies
  • Atom catalysis and nanocatalysis
  • Bioinspired Interfacial Materials and Devices
  • Carbon Nanomaterials
  • Environmental health and nanosafety aspects of nanotechnologies
  • Inorganic Nanomaterials and Metal-organic Frameworks
  • Modeling and Simulation of Nanostructures
  • Nanotechnology for Energy and Environmental Applications
  • Nanobiotechnology and Nanobiomaterials
  • Nanomedicine and Drug Delivery
  • Nanotechnology for Bioimaging and Diagnostic Applications
  • Nanophotonics and Optoelectronic Nanomaterials and Devices
  • Self-Assembly and Soft Nanomaterials
  • Young Scientist Forum

Submit your abstract

Plenary Speakers
Zhenan Bao, Stanford University, USA
Frank Caruso, The University of Melbourne, Australia
Ben Zhong Tang, The Hong Kong University of Science and Technology (HKUST), Hong Kong
View speakers

We welcome your participation and look forward to receiving your abstract.
Yours sincerely,

Conference Chair
Professor Yuliang Zhao, PhD
Editor-in-Chief, Nano Today
National Center for Nanoscience and Technology
The GBA National Institute for Nanotechnology Innovation

This Webinar is in zoom and at the same time in live stream for quality reasons.

During the meeting, you can write your questions that reach the chair of the CLINAM-Debate who passes them to the speakers. (Possibility to stay after the meeting for further oral debate in a zoom room) This Debate is open for up to 400 participants. The participation is free however, registration in order to get the link is mandatory. Please go to the registration contact page on our website.

THE FIRST CLINAM DEBATE (1/2021) July 8, 2021
4 hours 16.15 -20.15 (CEST Time)

Accelerating the RNA- Revolution in Medicine MORE


14 april | 12.00-12.45

Horizon Europe – hur ser prioriteringarna ut för avancerade material?I EU:s ramprogram för forskning 2021-2027 ökar forskningssatsningarna. Genom de tre pelarna excellent forskning, globala utmaningar och konkurrenskraft samt innovativa Europa så ska EU vara i framkant av global forskning och innovation.Avancerade material, som t.ex. nanoteknologi, är en möjliggörare för hållbar utveckling i många delar av samhället. Vad betyder det nya ramprogrammet för utvecklingen och användningen av avancerade material? Detta kommer Lars Montelius, GD för International Iberian Nanotechnology Laboratory (INL), att föreläsa om vid detta webinarium.

Tid: Onsdag 14 april kl. 12.00-12.45
Plats: Webinar, länk till seminariet skickas några dagar innan till anmälda deltagare.
Anmälan: Klicka här för att komma till anmälan

FÖRELÄSARENLars Montelius är förutom sitt uppdrag som GD för INL, professor i nanoteknologi vid Lunds universitet och bl.a. Past President för IUVSTA samt styrelseledamot i de europeiska teknikplattformarna NANOfutures och EUMaT. Han har också startat ett flertal företag inom nanoteknologiområdet. INL är också värd för årets EuroNanoForum. Läs mer på
SAAMsSwedish Association of Advanced Materials (SAAMs) är en förening för idéutbyte mellan akademi, industri och politiska beslutsfattare i Sverige kring avancerade material. Vi arbetar för att avancerade material ska komma till nytta för att stärka utvecklingen i samhället för ökad resurseffektivitet, snabbare läkemedelsutveckling och minskad miljöpåverkan. Läs mer på

Read the latest position paper of the ETPN about Nanomedicine, published in the Journal of Controlled Release!

The ETPN is very proud and happy to share with you today our latest publication in the Journal of Controlled Release : “Delivering the power of nanomedicine to patients today” (Germain, et al.).

This common position paper in open access is the best way to learn more about the real potential of Nanomedicine to concretely change the life of patients worldwide, how nanomedicine is improving therapeutic outcomes, the reality of its current translation to the clinic with some recent great successes in smarter drug delivery, and the action of the ETPN to create the best possible innovation-friendly ecosystem in Europe to mobilize the full community of Nanomedicine, in order to address better and faster complex pharmacological and medical challenges to tackle.

Download your copy of the article

• Nanomedicine unquestionably makes a difference for patients.

• Innovative nanomedicines open perspectives to make a difference outside oncology.

• High need for a harmonized international regulatory framework for nanomedicines

• Nanomedicine is a cross-sectorial and cross-technological solution for healthcare.

Go to website

Invitation; Wednesday 6th of May 2020, 16.00

Place: TBD, possibly digital


§ 1 Opening of the meeting

§ 2 Short update of NMN

§ 3 Election of Board Members
• Re-election (for two years) of Kristian Thulin, Obducat Technologies
• Tomas Rindzevicius, Danish Technical University
• Åsa Sjöholm Timén, Astra Zeneca and
• Ulf G Andersson, Medeon Science Park & Incubator

§ 4 Other matters (if pre-announced by any members)

§ 5 Closing of the meeting

Ulf G Andersson
Chairman NanoMed North
Please register as soon as possible but latest April 29, thank you.

This letter is to formally bring to your kind notice about the speaker opportunity available at the upcoming “16th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology” going to be held on May 04- 05, 2020 Amsterdam, Netherlands. In this regard we would be glad to have your research talk at the conference.

NanoPharma 2020 is a specially designed cluster conference. The main theme of the conference is “Challenges and Innovations in Nanomedicine and Pharmaceutical Nanotechnology” which covers wide range of critically important sessions.


All accepted abstracts will be published in the respective Journals.
Each abstract will receive a DOI provided by Cross Ref.
Special privileges on group registrations.
Chance of B2B meeting
Opportunity to organize a Workshop/Symposia and many more.

For more details of the conference:

We look forward to towards the confirmation of your participation by sending your abstract as per the attached template for committee review.